Skip to main content

Advertisement

Log in

Psychometric Evaluation of the Pediatric Quality of Life Enjoyment and Satisfaction Questionnaire in a General Youth Population

  • Original Article
  • Published:
Child Psychiatry & Human Development Aims and scope Submit manuscript

Abstract

Pediatric Quality of Life Enjoyment and Satisfaction Questionnaire is a brief 15-item self-report measure of quality of life and life satisfaction originally developed for clinical populations (6 to 17 years old). The current paper examines the initial factor structure proposed by the developers and underlying psychometric properties of the measure in a non-clinical population of teens. A cross-sectional adolescent sample (N = 3222) completed self-report measures as part of mental health promotion program. A confirmatory factor analysis was conducted with construct validity analyses. The original factor structure was replicated with strong internal consistency (Cronbach α = .912). Strong construct validity (e.g. resilience, well-being, depression, and anxiety) was found. Minimal differences were found based on gender, race, and ethnicity. PQ-LES-Q has strong, replicable psychometric properties, which makes it a generally reliable and valid assessment tool to evaluate the quality of life and life satisfaction in adolescents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Merikangas KR et al (2010) Lifetime prevalence of mental disorders in US adolescents: results from the national comorbidity survey replication-adolescent supplement (NCS-A). J Am Acad Child Adolesc Psychiatry 49(10):980–989

    Article  Google Scholar 

  2. Deighton J et al (2014) Measuring mental health and wellbeing outcomes for children and adolescents to inform practice and policy: a review of child self-report measures. Child Adolesc Psychiatry Ment Health 8(1):14

    Article  Google Scholar 

  3. Bastiaansen D et al (2004) Measuring quality of life in children referred for psychiatric problems: psychometric properties of the PedsQL 4.0 generic core scales. Qual Life Res 13(2):489–495

    Article  Google Scholar 

  4. Wallander JL, Koot HM (2016) Quality of life in children: a critical examination of concepts, approaches, issues, and future directions. Clin Psychol Rev 45:131–143

    Article  Google Scholar 

  5. Bertha EA, Balazs J (2013) Subthreshold depression in adolescence: a systematic review. Eur Child Adolesc Psychiatry 22(10):589–603

    Article  Google Scholar 

  6. Jonsson U et al (2017) Annual research review: quality of life and childhood mental and behavioural disorders–a critical review of the research. J Child Psychol Psychiatry 58(4):439–469

    Article  Google Scholar 

  7. Gartland D et al (2011) Development of a multi-dimensional measure of resilience in adolescents: the adolescent resilience questionnaire. BMC Med Res Methodol 11:134

    Article  Google Scholar 

  8. Watson HJ, Swan A, Nathan PR (2011) Psychiatric diagnosis and quality of life: the additional burden of psychiatric comorbidity. Compr Psychiatry 52(3):265–272

    Article  Google Scholar 

  9. Jacoby RJ et al (2014) Predictors of quality of life and functional impairment in obsessive–compulsive disorder. Compr Psychiatry 55(5):1195–1202

    Article  Google Scholar 

  10. Masellis M, Rector NA, Richter MA (2003) Quality of life in OCD: differential impact of obsessions, compulsions, and depression comorbidity. Can J Psychiatry 48(2):72–77

    Article  Google Scholar 

  11. Jawad S et al (2017) A pilot randomised controlled trial evaluating mini and conventional implant retained dentures on the function and quality of life of patients with an edentulous mandible. BMC Oral Health 17(1):53

    Article  Google Scholar 

  12. Walker DJ et al (2017) Quality of life in children and adolescents with bipolar I depression treated with olanzapine/fluoxetine combination. Child Adolesc Psychiatry Ment Health 11(1):34

    Article  Google Scholar 

  13. Rush AJ et al (2019) Toward a very brief quality of life enjoyment and satisfaction questionnaire. J Affect Disord 242:87–95

    Article  Google Scholar 

  14. Bastiaansen D et al (2004) Quality of life in children with psychiatric disorders: self-, parent, and clinician report. J Am Acad Child Adolesc Psychiatry 43(2):221–230

    Article  Google Scholar 

  15. Sawyer MG et al (2002) Health-related quality of life of children and adolescents with mental disorders. J Am Acad Child Adolesc Psychiatry 41(5):530–537

    Article  Google Scholar 

  16. Endicott J et al (2006) Pediatric quality of life enjoyment and satisfaction questionnaire (PQ-LES-Q): reliability and validity. J Am Acad Child Adolesc Psychiatry 45(4):401–407

    Article  Google Scholar 

  17. Endicott J et al (1993) Quality of life enjoyment and satisfaction questionnaire: a new measure. Psychopharmacol Bull 29(2):321–326

    PubMed  Google Scholar 

  18. Pohl RB, Wolkow RM, Clary CM (1998) Sertraline in the treatment of panic disorder: a double-blind multicenter trial. Am J Psychiatry 155(9):1189–1195

    Article  Google Scholar 

  19. Seidman SN, Rabkin JG (1998) Testosterone replacement therapy for hypogonadal men with SSRI-refractory depression. J Affect Disord 48(2–3):157–161

    Article  Google Scholar 

  20. Freeman EW et al (2000) Predictors of response to sertraline treatment of severe premenstrual syndromes. J Clin Psychiatry 61(8):579

    Article  Google Scholar 

  21. Rapaport MH et al (2000) Is placebo response the same as drug response in panic disorder? Am J Psychiatry 157(6):1014–1016

    Article  Google Scholar 

  22. Wellen B et al (2017) Examining the psychometric properties of the pediatric quality of life enjoyment and satisfaction questionnaire in two samples of youth with OCD. Child Psychiatry Hum Dev 48(1):180–188

    Article  Google Scholar 

  23. Bentley N, Hartley S, Bucci S (2019) Systematic review of self-report measures of general mental health and wellbeing in adolescent mental health. Clin Child Fam Psychol Rev 22(2):225–252

    Article  Google Scholar 

  24. Bernstein IH et al (2010) Psychometric properties of the quick inventory of depressive symptomatology in adolescents. Int J Methods Psychiatr Res 19(4):185–194

    Article  Google Scholar 

  25. Spitzer RL et al (2006) A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 166(10):1092–1097

    Article  Google Scholar 

  26. Bech P et al (2003) Measuring well-being rather than the absence of distress symptoms: a comparison of the SF-36 mental health subscale and the WHO-five well-being scale. Int J Methods Psychiatr Res 12(2):85–91

    Article  Google Scholar 

  27. Anderson JR, Killian M, Hughes JL, Rush AJ, Trivedi M (2020) The adolescent resilience questionnaire: validation of a shortened version in US youths. Front Psychol 11:3319

    Google Scholar 

  28. Muthén LK, M.B., Mplus user’s guide, 8th edn. 1998–2018: Muthén and Muthén

  29. Kline RB (2015) Principles and practice of structural equation modeling. Guilford publications, New York

    Google Scholar 

  30. Hu LT, Bentler PM (1999) Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Modeling 6(1):1–55

    Article  Google Scholar 

  31. Tucker LR, Lewis C (1973) A reliability coefficient for maximum likelihood factor analysis. Psychometrika 38(1):1–10

    Article  Google Scholar 

  32. Brown TA (2015) Confirmatory factor analysis for applied research. Guilford publications, New York

    Google Scholar 

  33. Hoffman ML (2001) Empathy and moral development: implications for caring and justice. Cambridge University Press, Cambridge

    Google Scholar 

Download references

Acknowledgements

The authors wish to thank the participants, families, staff, and colleagues who made this project possible. Bruce D. Grannemann, M.A., sadly died in the course of this project, but his efforts, energy, and dedication were invaluable for the research. The authors also thank Luis Gutierrez, MS, for his role in this project and the CDRC Risk and Resilience Network team. Finally, we thank Happy Carlock, B.A., for editorial support.

Funding

The Youth Aware of Mental Health program was funded in part by the Rees-Jones Foundation, REDCap (UL1 TR001105), and the Hersh Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the various funding organizations.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Madhukar H. Trivedi.

Ethics declarations

Conflict of interest

Dr. Hughes has served as Youth Aware of Mental Health (YAM) trainer, consulting for Mental Health in Mind International. Dr. Hughes also receives royalties from Guilford Press. A. John Rush has received consulting fees from Compass Inc., Curbstone Consultant LLC, Emmes Corp., Holmusk, Johnson and Johnson (Janssen), Liva-Nova, Neurocrine Biosciences Inc., Otsuka-US, Sunovion; speaking fees from Liva-Nova, Johnson and Johnson (Janssen); and royalties from Guilford Press and the University of Texas Southwestern Medical Center, Dallas, TX (for the Inventory of Depressive Symptoms and its derivatives). He is also named co-inventor on two patents: U.S. Patent No. 7,795,033: Methods to Predict the Outcome of Treatment with Antidepressant Medication, Inventors: McMahon FJ, Laje G, Manji H, Rush AJ, Paddock S, Wilson AS; and U.S. Patent No. 7,906,283: Methods to Identify Patients at Risk of Developing Adverse Events During Treatment with Antidepressant Medication, Inventors: McMahon FJ, Laje G, Manji H, Rush AJ, Paddock S.Dr. Trivedi has served as an adviser or consultant for Abbott Laboratories, Abdi Ibrahim, Akzo (Organon Pharmaceuticals), Alkermes, AstraZeneca, Axon Advisors, Bristol-Myers Squibb, Cephalon, Cerecor, CME Institute of Physicians, Concert Pharmaceuticals, Eli Lilly, Evotec, Fabre Kramer Pharmaceuticals, Forest Pharmaceuticals, GlaxoSmithKline, Janssen Global Services, Janssen Pharmaceutica Products, Johnson and Johnson PRD, Libby, Lundbeck, Meade Johnson, MedAvante, Medtronic, Merck, Mitsubishi Tanabe Pharma Development America, Naurex, Neuronetics, Otsuka Pharmaceuticals, Pamlab, Parke-Davis Pharmaceuticals, Pfizer, PgxHealth, Phoenix Marketing Solutions, Rexahn Pharmaceuticals, Ridge Diagnostics, Roche Products, Sepracor, Shire Development, Sierra, SK Life and Science, Sunovion, Takeda, Tal Medical/Puretech Venture, Targacept, Transcept, VantagePoint, Vivus, and Wyeth-Ayerst Laboratories; he has received grants or research support from the Agency for Healthcare Research and Quality, Cyberonics, NARSAD, NIDA, and NIMH. Drs. Anderson, Killian, Fuller, Byerly, and Lindow have no disclosures to report.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anderson, J.R., Killian, M., Fuller, A. et al. Psychometric Evaluation of the Pediatric Quality of Life Enjoyment and Satisfaction Questionnaire in a General Youth Population. Child Psychiatry Hum Dev 53, 546–553 (2022). https://doi.org/10.1007/s10578-021-01148-z

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10578-021-01148-z

Keywords

Navigation